Prompt testosterone treatment improves mental health of transgender, gender-diverse people

Receiving rapid access to testosterone therapy reduced feelings of gender dysphoria and led to a clinically significant reduction in depression as well as a 50% reduction in suicidality among transgender and gender diverse adults, according to research being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago.

Gender Affirmation Treatment Delivery Route May Affect Heart Health

Transgender and gender diverse (TGD) people assigned male at birth are at increased heart health risk. The delivery route of estrogen medication is known to affect heart health risk in cisgender women. However, research is lacking on how estrogen route affects heart health in the TGD population.

UCSF Surgeons Develop Effective Scarless Adam’s Apple Surgery

Feminizing chondrolaryngoplasty, also known as “tracheal shave,” is performed through an incision across the front of the neck. Regardless of the incision placement, it can leave undesirable ‘‘mark’’ on the patient. UCSF surgeons have developed and demonstrated the feasibility and clinical efficacy of a novel scarless transoral chondrolaryngoplasty (TOC) procedure.

Endocrine Society opposes Florida Department of Health policy on gender dysphoria treatment for children and adolescents

The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care.

Longest study of its kind reveals how gender-affirming hormone therapies impact obesity among U.S. transgender individuals

Researchers conducted the largest and longest observational study to date, using multiple body weight measurements among a racially and ethnically diverse population of gender diverse individuals treated at an academic medical center and non-profit community health center in Washington, D.C. The findings suggest that transgender patients taking gender-affirming hormone therapy should be monitored for changes in body weight, body mass index and for complications that may accompany high body weight, such as cardiovascular disease.

Researchers aim to modify fragmented health care system to reduce HIV incidence among trans women

There are an estimated one-million transgender adults living in the U.S. and an estimated 14% of transgender women are living with HIV. Researchers at UTHealth are studying if a combination intervention that combines HIV prevention services and hormonal therapy, supported by peer health navigation, will reduce HIV acquisition among this patient population.